MX2022006414A - Vacuna triple contra avibacterium paragallinarum y el virus de la encefalomielitis aviar y el virus de la viruela aviar. - Google Patents
Vacuna triple contra avibacterium paragallinarum y el virus de la encefalomielitis aviar y el virus de la viruela aviar.Info
- Publication number
- MX2022006414A MX2022006414A MX2022006414A MX2022006414A MX2022006414A MX 2022006414 A MX2022006414 A MX 2022006414A MX 2022006414 A MX2022006414 A MX 2022006414A MX 2022006414 A MX2022006414 A MX 2022006414A MX 2022006414 A MX2022006414 A MX 2022006414A
- Authority
- MX
- Mexico
- Prior art keywords
- virus
- fowl pox
- present
- avian encephalomyelitis
- avibacterium paragallinarum
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/295—Polyvalent viral antigens; Mixtures of viral and bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24071—Demonstrated in vivo effect
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32071—Demonstrated in vivo effect
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
La presente invención se refiere, entre otros, a una composición inmunogénica que comprende a) uno o más antígenos de Avibacterium paragallinarum y uno o más antígenos del virus de la encefalomielitis aviar y uno o más antígenos del virus de la viruela aviar; y b) un portador farmacéuticamente aceptable. Asimismo, la presente invención se refiere a métodos para inmunizar un sujeto, que comprenden administrar a dicho sujeto la composición inmunogénica de la presente invención. Además, la presente invención se refiere a métodos para tratar o prevenir signos clínicos causados por Avibacterium paragallinarum, el virus de la encefalomielitis aviar y el virus de la viruela aviar en un sujeto que lo necesita, en donde el método comprende administrar al sujeto una cantidad terapéuticamente eficaz de una composición inmunogénica de acuerdo con la presente invención.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19212630 | 2019-11-29 | ||
PCT/EP2020/083293 WO2021105167A1 (en) | 2019-11-29 | 2020-11-25 | Triple vaccine against avibacterium paragallinarum and avian encephalomyelitis virus and fowl pox virus |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022006414A true MX2022006414A (es) | 2022-06-22 |
Family
ID=68732996
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022006414A MX2022006414A (es) | 2019-11-29 | 2020-11-25 | Vacuna triple contra avibacterium paragallinarum y el virus de la encefalomielitis aviar y el virus de la viruela aviar. |
Country Status (10)
Country | Link |
---|---|
US (1) | US11541115B2 (es) |
EP (1) | EP4065163A1 (es) |
JP (1) | JP7342264B2 (es) |
KR (1) | KR20220110785A (es) |
CN (1) | CN114746113A (es) |
BR (1) | BR112022010147A2 (es) |
CO (1) | CO2022007006A2 (es) |
IL (1) | IL293167A (es) |
MX (1) | MX2022006414A (es) |
WO (1) | WO2021105167A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021105167A1 (en) * | 2019-11-29 | 2021-06-03 | Boehringer Ingelheim Vetmedica Gmbh | Triple vaccine against avibacterium paragallinarum and avian encephalomyelitis virus and fowl pox virus |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
JPS515045B2 (es) * | 1971-05-10 | 1976-02-17 | ||
JPS515045A (es) | 1974-06-29 | 1976-01-16 | Deyuaru Denshi Kk | |
GB8918689D0 (en) | 1989-08-16 | 1989-09-27 | Mini Agriculture & Fisheries | 25/15 vaccine |
JP2002154983A (ja) | 2000-11-20 | 2002-05-28 | Shionogi & Co Ltd | ヘモフィルス・パラガリナルムワクチン |
EP2829281B1 (en) * | 2012-03-22 | 2019-01-16 | KM Biologics Co., Ltd. | Lps vaccine |
CN103721253B (zh) | 2014-01-02 | 2015-06-10 | 青岛易邦生物工程有限公司 | 一种禽脑脊髓炎和鸡痘二联活疫苗 |
WO2021105167A1 (en) * | 2019-11-29 | 2021-06-03 | Boehringer Ingelheim Vetmedica Gmbh | Triple vaccine against avibacterium paragallinarum and avian encephalomyelitis virus and fowl pox virus |
-
2020
- 2020-11-25 WO PCT/EP2020/083293 patent/WO2021105167A1/en unknown
- 2020-11-25 US US17/104,457 patent/US11541115B2/en active Active
- 2020-11-25 KR KR1020227022307A patent/KR20220110785A/ko unknown
- 2020-11-25 EP EP20811329.0A patent/EP4065163A1/en active Pending
- 2020-11-25 MX MX2022006414A patent/MX2022006414A/es unknown
- 2020-11-25 BR BR112022010147A patent/BR112022010147A2/pt unknown
- 2020-11-25 CN CN202080081165.XA patent/CN114746113A/zh active Pending
- 2020-11-25 IL IL293167A patent/IL293167A/en unknown
- 2020-11-25 JP JP2022529378A patent/JP7342264B2/ja active Active
-
2022
- 2022-05-25 CO CONC2022/0007006A patent/CO2022007006A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20210162040A1 (en) | 2021-06-03 |
JP7342264B2 (ja) | 2023-09-11 |
IL293167A (en) | 2022-07-01 |
EP4065163A1 (en) | 2022-10-05 |
BR112022010147A2 (pt) | 2022-08-09 |
CO2022007006A2 (es) | 2022-06-10 |
CN114746113A (zh) | 2022-07-12 |
WO2021105167A1 (en) | 2021-06-03 |
US11541115B2 (en) | 2023-01-03 |
JP2023503430A (ja) | 2023-01-30 |
KR20220110785A (ko) | 2022-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
MX2018015506A (es) | Vacuna contra virus de bronquitis infecciosa. | |
EA201500848A1 (ru) | СПОСОБ ПОЛУЧЕНИЯ ОБОГАЩЕННОЙ IgG-КОМПОЗИЦИИ ИЗ ПЛАЗМЫ | |
EA201171032A1 (ru) | Схемы лечения с помощью вакцины против гриппа, связанного с пандемическими штаммами | |
MX2019012884A (es) | Terapia de combinacion. | |
JP2018505882A5 (es) | ||
NZ744233A (en) | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack | |
WO2017214596A8 (en) | Compositions and methods for preventing and treating zika virus infection | |
UA114286C2 (uk) | Спосіб лікування staphylococcus aureus | |
CR20220216A (es) | Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1 | |
AR112166A1 (es) | Composiciones terapéuticas y métodos para el tratamiento de hepatitis b | |
ZA202107428B (en) | Porcine circovirus type 3 (pcv3) vaccines, and production and uses thereof | |
EA201690115A1 (ru) | Комбинированные иммуногенные композиции | |
MX2022006414A (es) | Vacuna triple contra avibacterium paragallinarum y el virus de la encefalomielitis aviar y el virus de la viruela aviar. | |
MX2020000164A (es) | Formulaciones de isotretinoína para la mucosa oral y métodos para usar las mismas. | |
PH12020500194A1 (en) | Malaria vaccine | |
MX2021004907A (es) | Vacuna de ibv 4/91 con proteina espicular heterologa. | |
MX2021004859A (es) | Vacuna de ibv h52 con proteina espicular heterologa. | |
WO2019087133A8 (en) | Method of treating tendinopathy using interleukin-17 (il-17) antagonists | |
MX2022011651A (es) | Composicion farmaceutica para tratamiento de diabetes. | |
MX2021014349A (es) | Metodo para tratar cancer con una forma de dosificacion oral de un inhibidor de receptores de estrogeno-alfa. | |
PH12020550211A1 (en) | Nasal hepatitis b vaccine composition and method for producing same | |
AU2018347511A8 (en) | Periodontitis vaccine and related compositions and method of use | |
MX2021015561A (es) | Composiciones farmaceuticas que contienen dapansutrilo. | |
MX2022001742A (es) | Metodos para prevenir el dengue y la hepatitis a. |